June 8, 2020 — Marksans Pharma Ltd., India has voluntarily recalled extended-release metformin after FDA tests found high levels of a cancer-causing chemical.
The recall involves the diabetes drug metformin ER (500-mg) — Lot# XP9004 — in 100 count bottles with NDC code 49483-623-01 and expiration date 12/2020. It was distributed by Time-Cap Labs, Inc.
The FDA is recommending that patients keep taking their metformin, even if it has been recalled, until they can talk to their doctor about prescribing a replacement.
NDMA has been detected in other types of metformin ER, including medicines distibuted by Teva Pharmaceuticals, Amneal Pharmaceuticals, Apotex Corp., and other drug-makers.
Lawsuits have been filed by people who developed cancer after long-term exposure to NDMA in other medicines, such as Zantac® heartburn drugs and Valsartan blood pressure drugs.
NDMA is a chemical that is believed to cause cancer in humans. A growing number of lawsuits allege that NDMA exposure can cause breast cancer, bladder cancer, stomach cancer, and more.
Do I have a Metformin Lawsuit?
The Schmidt Firm, PLLC is currently accepting metformin induced injury cases in all 50 states. If you or somebody you know has been diagnosed with cancer after taking metformin that was contaminated with NDMA carcinogens, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.